Hypertension (HTN) is a leading cause of death and disability in nearly half of all Americans. Alarmingly, almost 50% of individuals with HTN are unaware of their condition, and only about 20% have it under proper medical control. Nurse practitioners (NPs) play a crucial role in managing HTN, particularly in patient communication, shared decision-making and clinical expertise. On today’s episode, Dr. Leslie Davis and Maria Bonanni explore how renal denervation (RDN) reduces hypertension, and discuss clinical trials, patient selection and recent regulatory approvals. They also highlight the NP’s role in screening and educating patients about RDN through shared decision-making.

This activity has expired and CE credit can no longer be claimed

This activity is supported by an independent medical educational grant from Medtronic